Copyright Reports & Markets. All rights reserved.

Global Intravenous (IV) Therapy and Vein Access Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Intravenous (IV) Therapy and Vein Access Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Infusion pumps
    • 1.4.3 Implantable Ports
    • 1.4.4 Intravenous Catheters
    • 1.4.5 Hypodermic Needles
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Intravenous (IV) Therapy and Vein Access Market Perspective (2015-2026)
  • 2.2 Global Intravenous (IV) Therapy and Vein Access Growth Trends by Regions
    • 2.2.1 Intravenous (IV) Therapy and Vein Access Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Intravenous (IV) Therapy and Vein Access Historic Market Share by Regions (2015-2020)
    • 2.2.3 Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Intravenous (IV) Therapy and Vein Access Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Intravenous (IV) Therapy and Vein Access Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Market Size
    • 3.1.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Revenue (2015-2020)
    • 3.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Intravenous (IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio
    • 3.2.1 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Therapy and Vein Access Revenue in 2019
  • 3.3 Intravenous (IV) Therapy and Vein Access Key Players Head office and Area Served
  • 3.4 Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
  • 3.5 Date of Enter into Intravenous (IV) Therapy and Vein Access Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Intravenous (IV) Therapy and Vein Access Historic Market Size by Type (2015-2020)
  • 4.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
  • 5.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 6.2 Intravenous (IV) Therapy and Vein Access Key Players in North America (2019-2020)
  • 6.3 North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 6.4 North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 7.2 Intravenous (IV) Therapy and Vein Access Key Players in Europe (2019-2020)
  • 7.3 Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 7.4 Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

8 China

  • 8.1 China Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 8.2 Intravenous (IV) Therapy and Vein Access Key Players in China (2019-2020)
  • 8.3 China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 8.4 China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 9.2 Intravenous (IV) Therapy and Vein Access Key Players in Japan (2019-2020)
  • 9.3 Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 9.4 Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 10.2 Intravenous (IV) Therapy and Vein Access Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

11 India

  • 11.1 India Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 11.2 Intravenous (IV) Therapy and Vein Access Key Players in India (2019-2020)
  • 11.3 India Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 11.4 India Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
  • 12.2 Intravenous (IV) Therapy and Vein Access Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
  • 12.4 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 B. Braun
    • 13.1.1 B. Braun Company Details
    • 13.1.2 B. Braun Business Overview
    • 13.1.3 B. Braun Intravenous (IV) Therapy and Vein Access Introduction
    • 13.1.4 B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020))
    • 13.1.5 B. Braun Recent Development
  • 13.2 Baxter International
    • 13.2.1 Baxter International Company Details
    • 13.2.2 Baxter International Business Overview
    • 13.2.3 Baxter International Intravenous (IV) Therapy and Vein Access Introduction
    • 13.2.4 Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.2.5 Baxter International Recent Development
  • 13.3 Becton Dickinson
    • 13.3.1 Becton Dickinson Company Details
    • 13.3.2 Becton Dickinson Business Overview
    • 13.3.3 Becton Dickinson Intravenous (IV) Therapy and Vein Access Introduction
    • 13.3.4 Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.3.5 Becton Dickinson Recent Development
  • 13.4 C. R. Bard
    • 13.4.1 C. R. Bard Company Details
    • 13.4.2 C. R. Bard Business Overview
    • 13.4.3 C. R. Bard Intravenous (IV) Therapy and Vein Access Introduction
    • 13.4.4 C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.4.5 C. R. Bard Recent Development
  • 13.5 Fresenius Kabi
    • 13.5.1 Fresenius Kabi Company Details
    • 13.5.2 Fresenius Kabi Business Overview
    • 13.5.3 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Introduction
    • 13.5.4 Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.5.5 Fresenius Kabi Recent Development
  • 13.6 Hospira(ICU Medical)
    • 13.6.1 Hospira(ICU Medical) Company Details
    • 13.6.2 Hospira(ICU Medical) Business Overview
    • 13.6.3 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Introduction
    • 13.6.4 Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.6.5 Hospira(ICU Medical) Recent Development
  • 13.7 Medtronic
    • 13.7.1 Medtronic Company Details
    • 13.7.2 Medtronic Business Overview
    • 13.7.3 Medtronic Intravenous (IV) Therapy and Vein Access Introduction
    • 13.7.4 Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.7.5 Medtronic Recent Development
  • 13.8 Smiths Group
    • 13.8.1 Smiths Group Company Details
    • 13.8.2 Smiths Group Business Overview
    • 13.8.3 Smiths Group Intravenous (IV) Therapy and Vein Access Introduction
    • 13.8.4 Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.8.5 Smiths Group Recent Development
  • 13.9 Teleflex
    • 13.9.1 Teleflex Company Details
    • 13.9.2 Teleflex Business Overview
    • 13.9.3 Teleflex Intravenous (IV) Therapy and Vein Access Introduction
    • 13.9.4 Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
    • 13.9.5 Teleflex Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Intravenous (IV) Therapy and Vein Access market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Therapy and Vein Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    B. Braun
    Baxter International
    Becton Dickinson
    C. R. Bard
    Fresenius Kabi
    Hospira(ICU Medical)
    Medtronic
    Smiths Group
    Teleflex

    Market segment by Type, the product can be split into
    Infusion pumps
    Implantable Ports
    Intravenous Catheters
    Hypodermic Needles
    Other
    Market segment by Application, split into
    Hospital
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now